Nanotechnology-donated ischemic stroke therapeutics: evolving strategies from the basic to the cutting-edge
Theranostics · 2026
DOI: 10.7150/thno.127504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Yuting Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Hauptthemen laut MEDLINE: Ischemic Stroke, Drug Delivery Systems, Neuroprotective Agents, Nanomedicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
Zitieren
APA
Wang, Y., Xu, J., Yan, W., Zhang, S., Luo, C., & Wang, Y. (2026). Nanotechnology-donated ischemic stroke therapeutics: evolving strategies from the basic to the cutting-edge. Theranostics. https://doi.org/10.7150/thno.127504
Vancouver
Wang Y, Xu J, Yan W, Zhang S, Luo C, Wang Y. Nanotechnology-donated ischemic stroke therapeutics: evolving strategies from the basic to the cutting-edge. Theranostics. 2026. doi:10.7150/thno.127504
BibTeX
@article{Wang2026,
author = {Wang, Yuting and Xu, Jiaxu and Yan, Wenxuan and Zhang, Shenwu and Luo, Cong and Wang, Yuequan},
title = {Nanotechnology-donated ischemic stroke therapeutics: evolving strategies from the basic to the cutting-edge},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.127504}
}
EUVIMED